GlaxoSmithKline launches SMS service to tackle counterfeit drugs

Health company GlaxoSmithKline has introduced an SMS service dubbed Hakikisha dawa to enhance patient safety by allowing people to check whether GSK branded drugs are real.

Health company GlaxoSmithKline has introduced an SMS service dubbed Hakikisha dawa to enhance patient safety by allowing people to check whether GSK branded drugs are real.

According to Dr, William Mwatu, GSK’s director of regulatory affairs for developing countries, the project will enable patients to verify that the medicine they are purchasing have been supplied by GSK. Currently the project will involve two GSK prescription products. Dr Mwatu explained that the aim of the project is to differentiate products supplied by firms from counterfeits in order to promote customer confidence and trust.

The project will enable consumers to initiate product verification and authentication by use of mobile phone SMS service. GSK say they intend the project will give consumers confidence that the products they are using has been supplied by GSK and have met the required standards for quality and safety.

The project has currently been launched in Kenya and GSK is running a similar project in Nigeria. The campaign will be rolled out in Kenya and subsequent launches will follow in Tanzania.

According to GSK, the company is bearing the full cost and patients will not pay any additional costs for the service. GSK has partnered with all the mobile service providers in Kenya to ensure the success of the initiative.

According to Dr Mwatu mobile phone technology in health is under explored and GSK believes the project will provide insights on how mobile technology can be used to enhance patient safety.

Similar initiatives have been launched before but on a lower scale hence patients are not aware about them. However, GSK promises to run this SMS project throughout the country to broaden awareness and encourage the patients to use it.

 

COMMENTS

WORDPRESS: 0